Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism TNFR1 inhibitors(Tumor necrosis factor receptor superfamily member 1A inhibitors) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Inflammatory Bowel Diseases | Preclinical | United States | 06 Oct 2025 | |
| Psoriasis | Preclinical | United States | 06 Oct 2025 | |
| Rheumatoid Arthritis | Preclinical | United States | 06 Oct 2025 |





